SELPEPCON™ is a novel and patentable method for the parallel synthesis of a large number of peptide-therapeutic cargo combinations to help boost the identification of the optimal cell-penetrating peptide (CPP) for cell screening in early stage drug development.
The SELPEPCON™ method originated at the Medical Research Council’s Laboratory of Molecular Biology headed up by Group Leader: Dr. Michael J. Gait. The SELPEPCON™ method was licenced to CRB on 5th September 2013 by MRC Technology on behalf of the MRC.
A library of cell-penetrating peptide (CPP)-cargo conjugates for rapid identification of optimal carriers are now available:
|PL-17-0001-24||Catalogue library (24-member) *|
|Quotation||Custom library (24-member)|
|Quotation||Custom library (48-member)|
|Quotation||Custom library (96-member)|
* A catalogue CPP library of 24 widely varying sequences selected from published scientific literature, such as Penetratin, Tat, R9, pVec… conjugated to the peptide nucleic acid or the peptide of your choice.